15249568

Source:http://linkedlifedata.com/resource/pubmed/id/15249568

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008976, umls-concept:C0009429, umls-concept:C0030705, umls-concept:C0034656, umls-concept:C0036043, umls-concept:C0164662, umls-concept:C0556895, umls-concept:C1099776
pubmed:issue	2
pubmed:dateCreated	2004-7-13
pubmed:abstractText	Tenofovir disoproxil fumarate (DF) is a once-daily nucleotide analogue reverse transcriptase inhibitor.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/15249568-15249576, http://linkedlifedata.com/resource/pubmed/commentcorrection/15249568-15507576
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7501160
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Adenine, http://linkedlifedata.com/resource/pubmed/chemical/Anti-HIV Agents, http://linkedlifedata.com/resource/pubmed/chemical/Benzoxazines, http://linkedlifedata.com/resource/pubmed/chemical/Lamivudine, http://linkedlifedata.com/resource/pubmed/chemical/Organophosphorus Compounds, http://linkedlifedata.com/resource/pubmed/chemical/Oxazines, http://linkedlifedata.com/resource/pubmed/chemical/Phosphonic Acids, http://linkedlifedata.com/resource/pubmed/chemical/Stavudine, http://linkedlifedata.com/resource/pubmed/chemical/efavirenz, http://linkedlifedata.com/resource/pubmed/chemical/tenofovir
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	1538-3598
pubmed:author	pubmed-author:903 Study Group, pubmed-author:ChengAndrew KAK, pubmed-author:CoakleyDion FDF, pubmed-author:DeJesusEdwinE, pubmed-author:GallantJoel EJE, pubmed-author:LuBiaoB, pubmed-author:MillerMichael DMD, pubmed-author:PozniakAnton LAL, pubmed-author:StaszewskiSchlomoS, pubmed-author:SuleimanJamal M A HJM, pubmed-author:TooleJohn JJJ
pubmed:issnType	Electronic
pubmed:day	14
pubmed:volume	292
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	191-201
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:15249568-Adenine, pubmed-meshheading:15249568-Adult, pubmed-meshheading:15249568-Anti-HIV Agents, pubmed-meshheading:15249568-Antiretroviral Therapy, Highly Active, pubmed-meshheading:15249568-Benzoxazines, pubmed-meshheading:15249568-Double-Blind Method, pubmed-meshheading:15249568-Drug Resistance, Viral, pubmed-meshheading:15249568-Female, pubmed-meshheading:15249568-HIV Infections, pubmed-meshheading:15249568-HIV-1, pubmed-meshheading:15249568-Humans, pubmed-meshheading:15249568-Lamivudine, pubmed-meshheading:15249568-Male, pubmed-meshheading:15249568-Middle Aged, pubmed-meshheading:15249568-Organophosphorus Compounds, pubmed-meshheading:15249568-Oxazines, pubmed-meshheading:15249568-Phosphonic Acids, pubmed-meshheading:15249568-Prospective Studies, pubmed-meshheading:15249568-Stavudine, pubmed-meshheading:15249568-Viral Load
pubmed:year	2004
pubmed:articleTitle	Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial.
pubmed:affiliation	Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Md 21287, USA. jgallant@jhmi.edu
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study